DPP4 and type 2 diabetes mellitus: The use of antidiabetic drugs (except for dipeptidyl peptidase-4 inhibitors), antihypertensives, and lipid-lowering drugs was more prevalent in the T2D subgroup with high income than in the T2D subgroups with middle and low income.